Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-05 4:47 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Global Healthcare Master Fund LP | 1,475,000 14.270% | 1,475,000 (New Position) | View |
| 2023-07-03 4:05 pm Purchase | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Global Healthcare Master Fund LP | 9,500,000 7.390% | 9,500,000 (New Position) | View |
| 2023-06-08 5:12 pm Purchase | 13D | GreenLight Biosciences Holdings PBC GRNA | Cormorant Global Healthcare Master Fund LP | 9,188,659 6.060% | 9,188,659 (New Position) | View |
| 2023-05-01 4:23 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | Cormorant Global Healthcare Master Fund LP | 3,200,000 9.330% | 3,200,000 (New Position) | View |
| 2023-04-03 4:40 pm Purchase | 13D | BIOMEA FUSION INC BMEA | Cormorant Global Healthcare Master Fund LP | 3,590,949 10.160% | 418,471 (+13.19%) | View |
| 2023-02-14 3:06 pm Sale | 13G | Edgewise Therapeutics Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,946,887 4.660% | -619,014 (-17.36%) | View |
| 2023-02-14 3:01 pm Purchase | 13G | Rain Oncology Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 2,733,977 9.990% | 796,176 (+41.09%) | View |
| 2022-02-14 3:16 pm Purchase | 13G | Rain Oncology Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,937,801 9.990% | 105,148 (+5.74%) | View |
| 2022-02-14 3:13 pm Purchase | 13G | Edgewise Therapeutics Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 3,565,901 7.230% | 974,987 (+37.63%) | View |
| 2021-05-18 4:08 pm Purchase | 13G | Edgewise Therapeutics Inc. EWTX | Cormorant Global Healthcare Master Fund LP | 2,590,914 5.260% | 2,590,914 (New Position) | View |
| 2021-05-07 4:01 pm Purchase | 13G | Rain Oncology Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,832,653 9.990% | 1,832,653 (New Position) | View |
| 2021-04-30 4:25 pm Purchase | 13D | BIOMEA FUSION INC BMEA | Cormorant Global Healthcare Master Fund LP | 3,172,478 11.030% | 3,172,478 (New Position) | View |